One-stage clotting versus chromogenic assays for assessing  recombinant factor VIII: two faces of a haemostasis coin.
Giuseppe
G
Lippi
Massimo
M
Franchini
Emmanuel J
EJ
Favaloro
D001681:Biological Assay / Q000379:methods*; D001780:Blood Coagulation Tests; D002863:Chromogenic Compounds / Q000032:analysis; D004340:Drug Contamination / Q000517:prevention & control*; D064420:Drug-Related Side Effects and Adverse Reactions; D005169:Factor VIII / Q000494:pharmacology / Q000592:standards*; D006467:Hemophilia A / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy; D006487:Hemostasis / Q000187:drug effects; D006801:Humans; D011786:Quality Control; D011994:Recombinant Proteins / Q000494:pharmacology / Q000592:standards*
D002863:Chromogenic Compounds; D011994:Recombinant Proteins; D005169:Factor VIII